Our study also demonstrated levels of chemokines, such as G-CSF and M-CSF, correlated with the development of ARDS and AKI in COVID-19 patients, suggesting a role of leukocyte maturation and activation in disease progression. The gene discussed is CSF1; the disease is COVID-19.